Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements Of Cash Flows

v3.22.2.2
Condensed Consolidated Statements Of Cash Flows - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash flows from operating activities:    
Net earnings (loss) $ (2,502) $ 624
Adjustments to reconcile net earnings (loss) to net cash provided by operating activities:    
Depreciation and amortization 371 396
Impairment of intangible assets 3,081  
Stock-based compensation 46 54
Share of (earnings) losses of affiliates, net 1 78
Realized and unrealized (gains) losses on financial instruments, net (29) (101)
(Gain) loss on sale of fixed assets, net (520)  
Gain on insurance proceeds (139)  
Insurance proceeds received for operating losses 96  
Deferred income tax expense (benefit) 45 (35)
Other, net (68) 15
Changes in operating assets and liabilities    
Decrease (increase) in accounts receivable 483 439
Decrease (increase) in inventory (163) (453)
Decrease (increase) in prepaid expenses and other assets 98 85
(Decrease) increase in trade accounts payable (418) (48)
(Decrease) increase in accrued and other liabilities (419) (339)
Net cash provided (used) by operating activities (37) 715
Cash flows from investing activities:    
Investments in and loans to cost and equity investees (7) (177)
Capital expenditures (171) (169)
Expenditures for television distribution rights (36) (184)
Cash proceeds from dispositions of investments 12 10
Proceeds from sale of fixed assets 701 40
Insurance proceeds 184  
Other investing activities, net 21 (3)
Net cash provided (used) by investing activities 704 (483)
Cash flows from financing activities:    
Borrowings of debt 2,069 394
Repayments of debt (2,577) (284)
Repurchases of Qurate Retail common stock   (216)
Withholding taxes on net settlements of stock-based compensation (7) (25)
Payments for issuances of financial instruments   (107)
Proceeds from settlements of financial instruments   88
Dividends paid to noncontrolling interest (39) (46)
Dividends paid to common shareholders (11) (14)
Other financing activities, net (6) (9)
Net cash provided (used) by financing activities (571) (219)
Effect of foreign currency exchange rates on cash, cash equivalents and restricted cash (59) (20)
Net increase (decrease) in cash, cash equivalents and restricted cash 37 (7)
Cash, cash equivalents and restricted cash at beginning of period 596 814
Cash, cash equivalents and restricted cash at end of period $ 633 $ 807